What is PharmaCyte Biotech, Inc. Common Stock's Market Cap?

PharmaCyte Biotech, Inc. Common Stock's Market Cap is $5.4M, based on as-reported figures from SEC (XBRL) filings.

What is PharmaCyte Biotech, Inc. Common Stock's Enterprise Value?

PharmaCyte Biotech, Inc. Common Stock's Enterprise Value is -$13.5M, based on as-reported figures from SEC (XBRL) filings.

What is PharmaCyte Biotech, Inc. Common Stock's Revenue (TTM)?

PharmaCyte Biotech, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is PharmaCyte Biotech, Inc. Common Stock's Net Income (TTM)?

PharmaCyte Biotech, Inc. Common Stock's Net Income (TTM) is -$19.4M, based on as-reported figures from SEC (XBRL) filings.

What is PharmaCyte Biotech, Inc. Common Stock's Diluted EPS (TTM)?

PharmaCyte Biotech, Inc. Common Stock's Diluted EPS (TTM) is -1.81, based on as-reported figures from SEC (XBRL) filings.

What is PharmaCyte Biotech, Inc. Common Stock's Net Debt?

PharmaCyte Biotech, Inc. Common Stock's Net Debt is -$18.9M, based on as-reported figures from SEC (XBRL) filings.

PharmaCyte Biotech, Inc. Common Stock (PMCB) Financial Statements

PharmaCyte Biotech, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG001S69496

XNAS · usd

0.50▲ 0.01 (2.25%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close0.49

Day's Range0.48 – 0.52

52-Week Range0.47 – 1.51

Volume221.3K

Avg Volume114.6K

Share Statistics

Shares Outstanding

Employees2

ExchangeXNAS

Listed2003-09-11

Share count as of July 24, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about PharmaCyte Biotech, Inc. Common Stock (PMCB)

What is PharmaCyte Biotech, Inc. Common Stock's Market Cap?: PharmaCyte Biotech, Inc. Common Stock's Market Cap is $5.4M, based on as-reported figures from SEC (XBRL) filings.
What is PharmaCyte Biotech, Inc. Common Stock's Enterprise Value?: PharmaCyte Biotech, Inc. Common Stock's Enterprise Value is -$13.5M, based on as-reported figures from SEC (XBRL) filings.
What is PharmaCyte Biotech, Inc. Common Stock's Revenue (TTM)?: PharmaCyte Biotech, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is PharmaCyte Biotech, Inc. Common Stock's Net Income (TTM)?: PharmaCyte Biotech, Inc. Common Stock's Net Income (TTM) is -$19.4M, based on as-reported figures from SEC (XBRL) filings.
What is PharmaCyte Biotech, Inc. Common Stock's Diluted EPS (TTM)?: PharmaCyte Biotech, Inc. Common Stock's Diluted EPS (TTM) is -1.81, based on as-reported figures from SEC (XBRL) filings.
What is PharmaCyte Biotech, Inc. Common Stock's Net Debt?: PharmaCyte Biotech, Inc. Common Stock's Net Debt is -$18.9M, based on as-reported figures from SEC (XBRL) filings.